Companies /Healthcare

Merck & Co Inc

NYSE: MRK Drug Manufacturers - General
$146.87
▼ $0.28 (−0.19%) today
Markets closed · 7:43am ET

MRK Coverage

Page 46
4:01pm ET
Investing

The 4 Stocks That Weighed on the DJIA Tuesday

thinkstockAugust 25, 2015: Markets opened higher on Tuesday and the markets quickly shook of the remaining effects of Monday’s tank job. WTI crude oil gained 2.8% ahead of Wednesday’s report on inventories,…

Paul Ausick
4:01pm ET
Investing

The 4 Stocks That Tanked the Dow on Thursday

thinkstockAugust 20, 2015: Markets opened lower on Thursday and things got worse from there. The bad news started in China, where equities lost 3.4% in Shanghai. Rumors that Greek Prime Minister Tsipras…

Paul Ausick
4:01pm ET
Investing

The 4 Stocks That Held the DJIA Higher on Thursday

thinkstockAugust 13, 2015: Markets opened slightly higher on Thursday following reassurances from the People’s Bank of China that it is nearly finished tinkering with the country’s currency and that the bank is…

Paul Ausick
9:45am ET
Health and Healthcare

Short Sellers Back Off Big Pharma

The short interest data have been released for the July 31 settlement date, and for most of the selected pharmaceutical stocks, short interest decreased.

Chris Lange
11:05am ET
Health and Healthcare

Positive Developments Around Ebola

Ebola fears have subsided and the development of a vaccine or related drugs has been put on the back burner for most, but one biotech made waves in the market Monday morning.

MRK
Chris Lange
4:01pm ET
Investing

The 4 Stocks That Boosted the DJIA on Wednesday

thinkstockJuly 29, 2015: Markets opened higher on Wednesday and two of the three major indexes spend all day trading above the break-even line; only the Nasdaq Composite took a brief visit into…

Paul Ausick
1:27pm ET
Health and Healthcare

Should Gilead Really Be Rated Underperform?

ThinkstockMost analysts seem to be behind the growth that Gilead Sciences Inc. (NASDAQ: GILD) has seen, namely in its Hepatitis C vaccines (HCV) Harvoni and Solvaldi. For the most part the resulting…

Chris Lange
9:55am ET
Health and Healthcare

Are Merck Earnings Enough?

ThinkstockMerck & Co. Inc. (NYSE: MRK) reported its second-quarter financial results Tuesday before the markets opened. The pharmaceutical giant had $0.86 in earnings per share (EPS) on $9.8 billion in revenue compared…

MRK
Chris Lange